Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000039 |
|---|---|
| Form Type | 4 |
| Filing Date | May 16, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
21,000
Total Value
$484,175.02
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | May 15, 2026 | Exercise/Conversion | 3,500 | $6.84 | $23,940.00 | 36,877 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 15, 2026 | Exercise/Conversion | 3,500 | $7.80 | $27,300.00 | 40,377 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 15, 2026 | Sale | 4,800 | $61.56 | $295,494.72 | 35,577 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 15, 2026 | Sale | 2,100 | $62.42 | $131,088.30 | 33,477 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 15, 2026 | Sale | 100 | $63.52 | $6,352.00 | 33,377 | Direct | โ | View Details | |
Chief Medical Officer | Employee Stock Option (right to buy) | Derivative | May 15, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 207,563 | Direct | โ | View Details | |
Chief Medical Officer | Employee Warrant (right to buy) | Derivative | May 15, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 178,992 | Direct | โ | View Details |